Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28-Reference-Cited by-同舟云学术

Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28

Published:2018-11 Issue: Volume:Volume 10 Page:6217-6226
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Tian Chuan,Ying Haifeng,Zhuang Rongyuan^ORCID,Zhang Xiaowei^ORCID,Lu Hongmin^ORCID,Wang Hui,Wang Shuowen,Li Qi,Wang Chungang,Cai Xun^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UGT1A1 genotype‐guided irinotecan dosing during neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A prospective analysis of SN‐38 concentration;International Journal of Cancer;2023-12-29

2. Bilirubin metabolism and UDP ‐glucuronosyltransferase 1A1 variants in Asians: Pathogenic implications and therapeutic response;The Kaohsiung Journal of Medical Sciences;2022-08

3. Ultra-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of 12 anti-tumor drugs in human plasma and its application in therapeutic drug monitoring;Journal of Pharmaceutical and Biomedical Analysis;2021-11

4. A Molecular‐Splicing Strategy for Constructing a Near‐Infrared Fluorescent Probe for UDP‐Glucuronosyltransferase 1A1;Angewandte Chemie International Edition;2021-10-07

5. A Molecular‐Splicing Strategy for Constructing a Near‐Infrared Fluorescent Probe for UDP‐Glucuronosyltransferase 1A1;Angewandte Chemie;2021-10-07